<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="cb97d4a0-89ed-407c-a763-209386b6f75c"><labelDrug name="Dopamine Hydrochloride and Dextrose"><Normalization/></labelDrug><generic name="Dopamine Hydrochloride"/><sentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.1" text="DOPAMINE HYDROCHLORIDE AND DEXTROSE (dopamine hydrochloride) injection, solution" type="negative"><entity charOffset="27:35" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.1.e.0" text="dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="DEXTROSE" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><entity charOffset="0:22" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.1.e.1" text="dopamine hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0282151" phraseText="DOPAMINE HYDROCHLORIDE" preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="37:59" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.1.e.2" text="dopamine hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0282151" phraseText="(dopamine hydrochloride" preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.1.e.1" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.1.e.0"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.1.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.1.e.2"/></sentence><sentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.2" text="Dopamine Hydrochloride and 5% Dextrose Injection, USP is a sterile, nonpyrogenic solution of Dopamine Hydrochloride, USP and Dextrose, USP in Water for Injection." type="negative"><entity charOffset="0:22" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.2.e.0" text="dopamine hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0282151" phraseText="Dopamine Hydrochloride" preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="93:115" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.2.e.1" text="dopamine hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0282151" phraseText="a sterile, nonpyrogenic solution of Dopamine Hydrochloride," preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="125:133" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.2.e.2" text="dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="Dextrose," preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><entity charOffset="27:38" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.2.e.3" text="5 dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0985452" phraseText="5% Dextrose Injection," preferredWord="Glucose 50 MG/ML" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.2.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.2.e.2"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.2.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.2.e.3"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.2.e.1" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.2.e.2"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.2.e.3" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.2.e.1"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.2.e.3" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.2.e.2"/></sentence><sentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.6" text="Solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products." type="negative"><entity charOffset="95:99" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.6.e.0" text="corn" type="Biomedical_Entity"><Normalization><mmtx cui="C1095906" phraseText="corn products." preferredWord="corn extract" semType="phsu"/><RxNorm RxCui="1323308"/></Normalization></entity><entity charOffset="87:91" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.6.e.1" text="corn" type="Biomedical_Entity"><Normalization><mmtx cui="C1095906" phraseText="to corn" preferredWord="corn extract" semType="phsu"/><RxNorm RxCui="1323308"/></Normalization></entity><entity charOffset="21:29" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.6.e.2" text="dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="dextrose" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.6.e.2" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.6.e.0"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.6.e.2" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.6.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.8" lineNumber="15" text="Patients who have been treated with monoamine oxidase (MAO) inhibitors prior to the administration of dopamine hydrochloride will require substantially reduced dosage. " type="regular"><entity charOffset="36:70" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.8.e.0" text="monoamine oxidase (MAO) inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0026457" phraseText="treated with monoamine oxidase (MAO) inhibitors" preferredWord="Monoamine Oxidase Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1565"/></Normalization></entity><entity charOffset="102:124" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.8.e.1" text="dopamine hydrochloride" type="Drug"><Normalization><mmtx cui="C0282151" phraseText="of dopamine hydrochloride" preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="152:166" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.8.e.2" text="reduced dosage" type="Caution_Interaction"/><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.8.ddi.1"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.8.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.8.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.8.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.8.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.8.e.1" trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.8.e.2" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.14" lineNumber="21" text="Do not add Dopamine Hydrochloride and 5% Dextrose Injection, USP to any alkaline diluent solution since dopamine hydrochloride is inactivated in alkaline solution." type="regular"><entity charOffset="104:126" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.14.e.0" text="dopamine hydrochloride" type="Drug"><Normalization><mmtx cui="C0282151" phraseText="dopamine hydrochloride" preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="145:162" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.14.e.1" text="alkaline solution" type="Substance"><Normalization><RxNorm RxCui="217815"/></Normalization></entity><entity charOffset="130:141" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.14.e.2" text="inactivated" type="Decrease_Interaction"/><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.14.ddi.1"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.14.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.14.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.14.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.14.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.14.e.1" trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.14.e.2" type="Decrease_Interaction"/></sentence><sentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.16" text="The intravenous administration of solutions may cause fluid overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema." type="negative"><entity charOffset="103:114" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.16.e.0" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C0013832" phraseText="resulting in dilution of serum electrolyte concentrations," preferredWord="Electrolytes" semType="inch, phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="146:155" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.16.e.1" text="congested" type="Biomedical_Entity"><Normalization><mmtx cui="C0700150" phraseText="congested" preferredWord="Congest" semType="strd, phsu, horm"/><RxNorm RxCui="1096425"/></Normalization></entity><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.16.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.16.e.1"/></sentence><sentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.23" text="Prior to treatment with dopamine hydrochloride, hypovolemia should be fully corrected, if possible, with either whole blood, plasma, or plasma expanders as indicated. " type="negative"><entity charOffset="136:152" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.23.e.0" text="plasma expanders" type="Biomedical_Entity"><Normalization><mmtx cui="C1268852" phraseText="plasma expanders" preferredWord="Plasma expander" semType="phsu"/><RxNorm RxCui="8397"/></Normalization></entity><entity charOffset="24:46" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.23.e.1" text="dopamine hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0282151" phraseText="with dopamine hydrochloride," preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.23.e.1" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.23.e.0"/></sentence><sentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.26" text="These conditions, which may also reduce the effectiveness and/or increase the incidence of adverse effects of dopamine, must be identified and corrected prior to, and concurrently with, administration of dopamine HCl." type="negative"><entity charOffset="204:216" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.26.e.0" text="dopamine hcl" type="Biomedical_Entity"><Normalization><mmtx cui="C0282151" phraseText="administration of dopamine HCl." preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="110:118" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.26.e.1" text="dopamine" type="Biomedical_Entity"><Normalization><mmtx cui="C0013030" phraseText="the incidence of adverse effects of dopamine," preferredWord="Dopamine" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.26.e.1" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.26.e.0"/></sentence><sentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.30" text="If a disproportionate rise in the diastolic pressure (i.e., marked decrease in the pulse pressure) is observed in patients receiving dopamine hydrochloride, the infusion rate should be decreased and the patient observed carefully for further evidence of predominant vasoconstrictor activity, unless such an effect is desired." type="negative"><entity charOffset="266:281" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.30.e.0" text="vasoconstrictor" type="Biomedical_Entity"><Normalization><mmtx cui="C0042397" phraseText="carefully for further evidence of predominant vasoconstrictor activity," preferredWord="Vasoconstrictor Agents" semType="phsu"/><RxNorm RxCui="11143"/></Normalization></entity><entity charOffset="133:155" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.30.e.1" text="dopamine hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0282151" phraseText="dopamine hydrochloride," preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.30.e.1" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.30.e.0"/></sentence><sentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.33" text="If hypotension persists, dopamine HCl should be discontinued and a more potent vasoconstrictor agent such as norepinephrine should be administered." type="negative"><entity charOffset="25:37" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.33.e.0" text="dopamine hcl" type="Biomedical_Entity"><Normalization><mmtx cui="C0282151" phraseText="dopamine HCl" preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="79:94" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.33.e.1" text="vasoconstrictor" type="Biomedical_Entity"><Normalization><mmtx cui="C0042397" phraseText="a more potent vasoconstrictor agent such as norepinephrine" preferredWord="Vasoconstrictor Agents" semType="phsu"/><RxNorm RxCui="11143"/></Normalization></entity><entity charOffset="109:123" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.33.e.2" text="norepinephrine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028351" phraseText="a more potent vasoconstrictor agent such as norepinephrine" preferredWord="Norepinephrine" semType="phsu, orch, nsba"/><RxNorm RxCui="7508"/></Normalization></entity><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.33.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.33.e.1"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.33.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.33.e.2"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.33.e.1" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.33.e.2"/></sentence><sentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.39" text="Dopamine Hydrochloride and 5% Dextrose Injection, USP should be infused into a large vein whenever possible to prevent the possibility of extravasation into tissue adjacent to the infusion site. " type="negative"><entity charOffset="0:22" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.39.e.0" text="dopamine hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0282151" phraseText="Dopamine Hydrochloride" preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="27:38" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.39.e.1" text="5 dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0985452" phraseText="5% Dextrose Injection," preferredWord="Glucose 50 MG/ML" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.39.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.39.e.1"/></sentence><sentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.46" text="To prevent sloughing and necrosis in ischemic areas, the area should be infiltrated as soon as possible with 10 to 15 mL of 0.9% Sodium Chloride Injection, USP containing from 5 to 10 mg phentolamine, an adrenergic blocking agent. " type="negative"><entity charOffset="204:229" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.46.e.0" text="adrenergic blocking agent" type="Biomedical_Entity"><Normalization><mmtx cui="C0242889" phraseText="an adrenergic blocking agent." preferredWord="Adrenergic Antagonists" semType="phsu"/><RxNorm RxCui="1430615"/></Normalization></entity><entity charOffset="124:154" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.46.e.1" text="0.9 sodium chloride injection" type="Biomedical_Entity"><Normalization><mmtx cui="C0980221" phraseText="of 0.9% Sodium Chloride Injection," preferredWord="Sodium Chloride 0.154 MEQ/ML Injectable Solution" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="187:199" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.46.e.2" text="phentolamine" type="Biomedical_Entity"><Normalization><mmtx cui="C0031448" phraseText="to 10 mg phentolamine," preferredWord="Phentolamine" semType="phsu, orch"/><RxNorm RxCui="8153"/></Normalization></entity><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.46.e.1" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.46.e.0"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.46.e.2" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.46.e.0"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.46.e.1" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.46.e.2"/></sentence><sentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.53" text="Close monitoring of the following indices - urine flow, cardiac output and blood pressure - during dopamine hydrochloride infusion is necessary as in the case of any adrenergic agent." type="negative"><entity charOffset="99:121" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.53.e.0" text="dopamine hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0282151" phraseText="during dopamine hydrochloride infusion" preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="166:182" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.53.e.1" text="adrenergic agent" type="Biomedical_Entity"><Normalization><mmtx cui="C0001637" phraseText="as in the case of any adrenergic agent." preferredWord="Adrenergic Agents" semType="phsu"/><RxNorm RxCui="1430615"/></Normalization></entity><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.53.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.53.e.1"/></sentence><sentence biomedicalEntities="1" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.54" lineNumber="74" text="Solutions containing dextrose should be used with caution in patients with known subclinical or overt diabetes mellitus." type="irregular"><entity charOffset="0:29" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.54.e.0" text="Solutions containing dextrose" type="Drug_Class"><Normalization><mmtx cui="C0017725" phraseText="dextrose" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="40:57" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.54.e.1" text="used with caution" type="Caution_Interaction"/><entity charOffset="102:119" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.54.e.3" text="diabetes mellitus" type="SPAN"><Normalization><mmtx cui="C0543567" phraseText="overt diabetes mellitus." preferredWord="Diabetes mellitus, overt" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.54.ddi.1"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.54.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.54.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.54.e.3"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.53" text="Close monitoring of the following indices - urine flow, cardiac output and blood pressure - during dopamine hydrochloride infusion is necessary as in the case of any adrenergic agent."><entity charOffset="99:121" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.53.e.0" text="dopamine hydrochloride" type="Drug"><Normalization><mmtx cui="C0282151" phraseText="during dopamine hydrochloride infusion" preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.54.e.0"/></sentence><sentence biomedicalEntities="4" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60" lineNumber="86" text="Cyclopropane or halogenated hydrocarbon anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines, such as dopamine. " type="regular"><entity charOffset="100:124" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.0" text="sensitize the myocardium" type="Specific_Interaction"/><entity charOffset="0:12" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.2" text="Cyclopropane" type="Drug"><Normalization><mmtx cui="C0010587" phraseText="Cyclopropane" preferredWord="cyclopropane" semType="phsu, orch"/><RxNorm RxCui="3004"/></Normalization></entity><entity charOffset="16:51" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.3" text="halogenated hydrocarbon anesthetics" type="Drug_Class"><Normalization><mmtx cui="C0002932" phraseText="halogenated hydrocarbon anesthetics" preferredWord="Anesthetics" semType="phsu"/><RxNorm RxCui="1470026"/></Normalization></entity><entity charOffset="150:191" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.4" text="intravenously administered catecholamines" type="Drug_Class"><Normalization><mmtx cui="C0007412" phraseText="the myocardium to the action of certain intravenously administered catecholamines," preferredWord="Catecholamines" semType="phsu, nsba"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="201:209" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.5" text="dopamine" type="Drug"><Normalization><mmtx cui="C0013030" phraseText="such as dopamine." preferredWord="Dopamine" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><drugClassMembership drug="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.5" drugClass="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.4"/><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.ddi.1"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.0"><relations><relation type="hasObject"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.3" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.4" trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.2" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.4" trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.0" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.2" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.3"/></sentence><sentence biomedicalEntities="0" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.61" lineNumber="86" text="This interaction appears to be related both to pressor activity and to the beta-adrenergic stimulating properties of these catecholamines, and may produce ventricular arrhythmias. " type="irregular"><entity charOffset="155:178" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.61.e.0" text="ventricular arrhythmias" type="Specific_Interaction"/><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.61.ddi.1"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.61.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60" text="Cyclopropane or halogenated hydrocarbon anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines, such as dopamine. "><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.4"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60" text="Cyclopropane or halogenated hydrocarbon anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines, such as dopamine. "><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.2"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60" text="Cyclopropane or halogenated hydrocarbon anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines, such as dopamine. "><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.60.e.3"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="3" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.62" lineNumber="86" text="Therefore, EXTREME CAUTION should be exercised when administering dopamine HCl to patients receiving cyclopropane or halogenated hydrocarbon anesthetics. " type="regular"><entity charOffset="11:26" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.62.e.0" text="EXTREME CAUTION" type="Caution_Interaction"/><entity charOffset="66:78" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.62.e.2" text="dopamine HCl" type="Drug"><Normalization><mmtx cui="C0282151" phraseText="administering dopamine HCl to patients" preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="101:113" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.62.e.3" text="cyclopropane" type="Drug"><Normalization><mmtx cui="C0010587" phraseText="cyclopropane" preferredWord="cyclopropane" semType="phsu, orch"/><RxNorm RxCui="3004"/></Normalization></entity><entity charOffset="117:152" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.62.e.4" text="halogenated hydrocarbon anesthetics" type="Drug_Class"><Normalization><mmtx cui="C0002932" phraseText="halogenated hydrocarbon anesthetics." preferredWord="Anesthetics" semType="phsu"/><RxNorm RxCui="1470026"/></Normalization></entity><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.62.ddi.1"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.62.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.62.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.62.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.62.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.62.e.2" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.62.e.4" trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.62.e.0" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.62.e.2" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.62.e.3" trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.62.e.0" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.62.e.3" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.62.e.4"/></sentence><sentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.63" text="Results of studies in animals indicate that dopamine-induced ventricular arrhythmias during anesthesia can be reversed by propranolol." type="negative"><entity charOffset="44:52" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.63.e.0" text="dopamine" type="Biomedical_Entity"><Normalization><mmtx cui="C0013030" phraseText="that dopamine-induced ventricular arrhythmias during anesthesia" preferredWord="Dopamine" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="122:133" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.63.e.1" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="reversed by propranolol." preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="92:102" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.63.e.2" text="anesthesia" type="Biomedical_Entity"><Normalization><mmtx cui="C0002932" phraseText="that dopamine-induced ventricular arrhythmias during anesthesia" preferredWord="Anesthetics" semType="phsu"/><RxNorm RxCui="239756"/></Normalization></entity><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.63.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.63.e.1"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.63.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.63.e.2"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.63.e.2" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.63.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.64" lineNumber="88" text="Because dopamine is metabolized by monoamine oxidase (MAO), inhibition of this enzyme prolongs and potentiates the effect of dopamine. " type="regular"><entity charOffset="35:58|60:70" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.64.e.0" text="monoamine oxidase (MAO) inhibition" type="Drug_Class"><Normalization><RxNorm RxCui="1565"/></Normalization></entity><entity charOffset="125:133" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.64.e.1" text="dopamine" type="Drug"><Normalization><mmtx cui="C0013030" phraseText="the effect of dopamine." preferredWord="Dopamine" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="86:94|111:121" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.64.e.2" text="prolongs the effect" type="Increase_Interaction"/><entity charOffset="99:121" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.64.e.4" text="potentiates the effect" type="Increase_Interaction"/><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.64.ddi.1"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.64.e.2"><relations><relation type="hasObject"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.64.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.64.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.64.ddi.2"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.64.e.4"><relations><relation type="hasObject"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.64.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.64.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.64.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.64.e.1" trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.64.e.2" type="Increase_Interaction"/></sentence><sentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.65" text="Patients who have been treated with MAO inhibitors within two to three weeks prior to the administration of dopamine should receive initial doses of dopamine hydrochloride no greater than one-tenth (1/10) of the usual dose." type="negative"><entity charOffset="149:171" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.65.e.0" text="dopamine hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0282151" phraseText="initial doses of dopamine hydrochloride" preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="36:50" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.65.e.1" text="mao inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0026457" phraseText="treated with MAO inhibitors" preferredWord="Monoamine Oxidase Inhibitors" semType="phsu, orch"/><RxNorm RxCui="7029"/></Normalization></entity><entity charOffset="108:116" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.65.e.2" text="dopamine" type="Biomedical_Entity"><Normalization><mmtx cui="C0013030" phraseText="of dopamine" preferredWord="Dopamine" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.65.e.1" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.65.e.0"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.65.e.2" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.65.e.0"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.65.e.1" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.65.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66" lineNumber="90" text="Concurrent administration of low-dose dopamine HCl and diuretic agents may produce an additive or potentiating effect on urine flow." type="regular"><entity charOffset="29:50" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66.e.0" text="low-dose dopamine HCl" type="Drug"><Normalization><mmtx cui="C0282151" phraseText="Concurrent administration of low-dose dopamine HCl" preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="832098"/></Normalization></entity><entity charOffset="55:70" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66.e.1" text="diuretic agents" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="diuretic agents" preferredWord="Diuretics" semType="phsu"/><mmtx cui="C1254351" phraseText="diuretic agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="86:94|111:131" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66.e.2" text="additive effect on urine flow" type="Specific_Interaction"/><entity charOffset="98:131" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66.e.4" text="potentiating effect on urine flow" type="Specific_Interaction"/><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66.ddi.1"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66.ddi.2"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66.e.1" trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66.e.2" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66.e.1" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66.e.1" trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.66.e.4" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.67" lineNumber="92" text="Tricyclic antidepressants may potentiate the cardiovascular effects of adrenergic agents." type="regular"><entity charOffset="0:25" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.67.e.0" text="Tricyclic antidepressants" type="Drug_Class"><Normalization><mmtx cui="C0003290" phraseText="Tricyclic antidepressants" preferredWord="Tricyclic Antidepressive Agents" semType="phsu"/><RxNorm RxCui="928"/></Normalization></entity><entity charOffset="71:88" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.67.e.1" text="adrenergic agents" type="Drug_Class"><Normalization><mmtx cui="C0007220" phraseText="the cardiovascular effects of adrenergic agents." preferredWord="Cardiovascular Agents" semType="phsu"/><RxNorm RxCui="1430615"/></Normalization></entity><entity charOffset="30:67" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.67.e.2" text="potentiate the cardiovascular effects" type="Specific_Interaction"/><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.67.ddi.1"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.67.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.67.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.67.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.67.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.67.e.1" trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.67.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.68" lineNumber="94" text="Cardiac effects of dopamine are antagonized by beta-adrenergic blocking agents, such as propranolol and metoprolol. " type="regular"><entity charOffset="0:15|28:43" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.68.e.0" text="Cardiac effects are antagonized" type="Specific_Interaction"/><entity charOffset="47:78" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.68.e.2" text="beta-adrenergic blocking agents" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="antagonized by beta-adrenergic blocking agents," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="19:27" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.68.e.3" text="dopamine" type="Drug"><Normalization><mmtx cui="C0013030" phraseText="Cardiac effects of dopamine" preferredWord="Dopamine" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="88:99" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.68.e.4" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="such as propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="104:114" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.68.e.5" text="metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="metoprolol." preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><drugClassMembership drug="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.68.e.4" drugClass="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.68.e.2"/><drugClassMembership drug="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.68.e.5" drugClass="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.68.e.2"/><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.68.ddi.1"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.68.e.0"><relations><relation type="hasObject"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.68.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.68.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.68.e.3" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.68.e.2" trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.68.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.69" lineNumber="94" text="The peripheral vasoconstriction caused by high doses of dopamine HCl is antagonized by alpha-adrenergic blocking agents. " type="regular"><entity charOffset="4:31|69:83" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.69.e.0" text="peripheral vasoconstriction is antagonized" type="Specific_Interaction"/><entity charOffset="56:68" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.69.e.2" text="dopamine HCl" type="Drug"><Normalization><mmtx cui="C0282151" phraseText="caused by high doses of dopamine HCl" preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="87:119" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.69.e.3" text="alpha-adrenergic blocking agents" type="Drug_Class"><Normalization><mmtx cui="C0001641" phraseText="antagonized by alpha-adrenergic blocking agents." preferredWord="Adrenergic alpha-Antagonists" semType="phsu"/><RxNorm RxCui="1023426"/></Normalization></entity><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.69.ddi.1"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.69.e.0"><relations><relation type="hasObject"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.69.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.69.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.69.e.2" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.69.e.3" trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.69.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.70" text="Dopamine-induced renal and mesenteric vasodilation is not antagonized by either alpha- or beta-adrenergic blocking agents." type="negative"><entity charOffset="0:8" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.70.e.0" text="dopamine" type="Biomedical_Entity"><Normalization><mmtx cui="C0013030" phraseText="Dopamine-induced renal" preferredWord="Dopamine" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="90:121" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.70.e.1" text="beta-adrenergic blocking agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta-adrenergic blocking agents." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.70.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.70.e.1"/></sentence><sentence biomedicalEntities="4" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71" lineNumber="96" text="Butyrophenones (such as haloperidol) and phenothiazines can suppress the dopaminergic renal and mesenteric vasodilation induced with low-dose dopamine infusion." type="regular"><entity charOffset="0:14" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.0" text="Butyrophenones" type="Drug_Class"><Normalization><mmtx cui="C0006525" phraseText="Butyrophenones" preferredWord="Butyrophenones" semType="phsu, orch"/><RxNorm RxCui="1856"/></Normalization></entity><entity charOffset="24:35" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.1" text="haloperidol" type="Drug"><Normalization><mmtx cui="C0018546" phraseText="such as haloperidol" preferredWord="Haloperidol" semType="phsu, orch"/><RxNorm RxCui="26420"/></Normalization></entity><entity charOffset="41:55" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.3" text="phenothiazines" type="Drug_Class"><Normalization><mmtx cui="C0031434" phraseText="phenothiazines" preferredWord="phenothiazine" semType="phsu, orch"/><mmtx cui="C0031436" phraseText="phenothiazines" preferredWord="Phenothiazines" semType="phsu, orch"/><mmtx cui="C0304370" phraseText="phenothiazines" preferredWord="Phenothiazine derivatives" semType="phsu, orch"/><RxNorm RxCui="1437064"/></Normalization></entity><entity charOffset="142:159" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.4" text="dopamine infusion" type="Drug"><Normalization><mmtx cui="C0013030" phraseText="induced with low-dose dopamine infusion." preferredWord="Dopamine" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="60:72|96:119" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.5" text="suppress the mesenteric vasodilation" type="Specific_Interaction"/><entity charOffset="60:72|86:91|107:119" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.7" text="suppress the renal vasodilation" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.1" drugClass="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.0"/><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.ddi.1"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.ddi.2"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.4" trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.5" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.3" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.4" trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.5" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.71.e.3"/></sentence><sentence biomedicalEntities="4" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72" lineNumber="98" text="The concomitant use of vasopressors, vasoconstrictor agents (such as ergonovine) and some oxytocic drugs may result in severe hypertension." type="irregular"><entity charOffset="119:138" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.0" text="severe hypertension" type="Specific_Interaction"><Normalization><mmtx cui="C0020538" phraseText="result in severe hypertension." preferredWord="Hypertensive disease" semType="dsyn"/></Normalization></entity><entity charOffset="23:35" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.2" text="vasopressors" type="Drug_Class"><Normalization><mmtx cui="C0042397" phraseText="The concomitant use of vasopressors," preferredWord="Vasoconstrictor Agents" semType="phsu"/><RxNorm RxCui="1098"/></Normalization></entity><entity charOffset="37:59" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.3" text="vasoconstrictor agents" type="Drug_Class"><Normalization><mmtx cui="C0042397" phraseText="vasoconstrictor agents" preferredWord="Vasoconstrictor Agents" semType="phsu"/><RxNorm RxCui="11143"/></Normalization></entity><entity charOffset="69:79" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.4" text="ergonovine" type="Drug"><Normalization><mmtx cui="C0014704" phraseText="such as ergonovine" preferredWord="Ergonovine" semType="phsu, orch"/><RxNorm RxCui="4021"/></Normalization></entity><entity charOffset="90:104" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.6" text="oxytocic drugs" type="Drug_Class"><Normalization><mmtx cui="C0030094" phraseText="some oxytocic drugs" preferredWord="Oxytocics" semType="phsu"/><RxNorm RxCui="7823"/></Normalization></entity><drugClassMembership drug="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.4" drugClass="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.3"/><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.ddi.1"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.6"/></relation><relation type="hasObject"><labelDrug text="Dopamine Hydrochloride and Dextrose"/><normalization/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.2" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.3"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.2" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.6"/><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.3" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.6"/><pair ddi="true" e1="labelDrug" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.72.e.6"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.73" lineNumber="100" text="Administration of phenytoin to patients receiving dopamine HCl has been reported to lead to hypotension and bradycardia. " type="regular"><entity charOffset="18:27" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.73.e.0" text="phenytoin" type="Drug"><Normalization><mmtx cui="C0031507" phraseText="Administration of phenytoin" preferredWord="Phenytoin" semType="phsu, orch"/><RxNorm RxCui="8183"/></Normalization></entity><entity charOffset="50:62" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.73.e.1" text="dopamine HCl" type="Drug"><Normalization><mmtx cui="C0282151" phraseText="dopamine HCl" preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="92:103" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.73.e.2" text="hypotension" type="Specific_Interaction"/><entity charOffset="108:119" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.73.e.4" text="bradycardia" type="Specific_Interaction"/><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.73.ddi.1"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.73.e.2"><relations><relation type="hasObject"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.73.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.73.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.73.ddi.2"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.73.e.4"><relations><relation type="hasObject"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.73.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.73.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.73.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.73.e.1" trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.73.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.74" lineNumber="100" text="It is suggested that in patients receiving dopamine HCl, alternatives to phenytoin should be considered if anticonvulsant therapy is needed." type="regular"><entity charOffset="57:69|93:103" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.74.e.0" text="alternatives considered" type="Caution_Interaction"/><entity charOffset="73:82" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.74.e.2" text="phenytoin" type="Drug"><Normalization><mmtx cui="C0031507" phraseText="alternatives to phenytoin" preferredWord="Phenytoin" semType="phsu, orch"/><RxNorm RxCui="8183"/></Normalization></entity><entity charOffset="43:55" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.74.e.3" text="dopamine HCl" type="Drug"><Normalization><mmtx cui="C0282151" phraseText="dopamine HCl," preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><drugInteraction id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.74.ddi.1"><interaction trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.74.e.0"><relations><relation type="hasObject"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.74.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.74.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.74.e.3" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.74.e.2" trigger="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.74.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.77" text="Dopamine Hydrochloride and 5% Dextrose Injection, USP is administered intravenously through a suitable intravenous catheter or needle. " type="negative"><entity charOffset="0:22" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.77.e.0" text="dopamine hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0282151" phraseText="Dopamine Hydrochloride" preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><entity charOffset="27:38" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.77.e.1" text="5 dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0985452" phraseText="5% Dextrose Injection," preferredWord="Glucose 50 MG/ML" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.77.e.0" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.77.e.1"/></sentence><sentence id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.83" text="Drug additives should not be made to Dopamine Hydrochloride and 5% Dextrose Injection, USP." type="negative"><entity charOffset="64:75" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.83.e.0" text="5 dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0985452" phraseText="5% Dextrose Injection," preferredWord="Glucose 50 MG/ML" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="37:59" id="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.83.e.1" text="dopamine hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0282151" phraseText="made to Dopamine Hydrochloride" preferredWord="Dopamine Hydrochloride" semType="phsu, orch, nsba"/><RxNorm RxCui="82010"/></Normalization></entity><pair ddi="false" e1="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.83.e.1" e2="Dailymed.cb97d4a0-89ed-407c-a763-209386b6f75c.s.83.e.0"/></sentence><positiveExamples number="20"/><negativeExamples number="36"/></document>